Status:
COMPLETED
Breast Cancer Tumor Care Observational Programme
Lead Sponsor:
AstraZeneca
Conditions:
Post Menopausal
Arthralgia
Eligibility:
FEMALE
Brief Summary
The purpose of this study is to investigate efficacy and tolerability under anastrozole (Arimidex) treatment.
Eligibility Criteria
Inclusion
- Postmenopausal women
- Already on upfront Arimidex Therapy (Start 1-4 weeks before)
- HR+
Exclusion
- Premenopausal women
- Tamoxifen switch patients
Key Trial Info
Start Date :
February 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2009
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT00660244
Start Date
February 1 2008
End Date
December 1 2009
Last Update
June 6 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Graz, Austria